Approvals/TGA/VARIVAX REFRIGERATED varicella virus vaccine live powder for injection vial with sterile diluent vial

Approved

STANDARD

VARIVAX REFRIGERATED varicella virus vaccine live powder for injection vial with sterile diluent vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e00d742baaa62c7e
Product Name: VARIVAX REFRIGERATED varicella virus vaccine live powder for injection vial with sterile diluent vial
Artg Id: 337387
Artg Name: VARIVAX REFRIGERATED varicella virus vaccine live powder for injection vial with sterile diluent vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2020-07-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-01554-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-01552-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e00d742baaa62c7e

Type

Standard